Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan

Comprehensive cancer genome profiling (CGP) has been nationally reimbursed in Japan since June 2019. Less than 10% of the patients have been reported to undergo recommended treatment. Todai OncoPanel (TOP) is a dual DNA–RNA panel as well as a paired tumor–normal matched test. Two hundred patients un...

Descripción completa

Detalles Bibliográficos
Autores principales: Kage, Hidenori, Shinozaki‐Ushiku, Aya, Ishigaki, Kazunaga, Sato, Yusuke, Tanabe, Masahiko, Tanaka, Shota, Tanikawa, Michihiro, Watanabe, Kousuke, Kato, Shingo, Akagi, Kiwamu, Uchino, Keita, Mitani, Kinuko, Takahashi, Shunji, Miura, Yuji, Ikeda, Sadakatsu, Kojima, Yasushi, Watanabe, Kiyotaka, Mochizuki, Hitoshi, Yamaguchi, Hironori, Kawazoe, Yoshimasa, Kashiwabara, Kosuke, Kohsaka, Shinji, Tatsuno, Kenji, Ushiku, Tetsuo, Ohe, Kazuhiko, Yatomi, Yutaka, Seto, Yasuyuki, Aburatani, Hiroyuki, Mano, Hiroyuki, Miyagawa, Kiyoshi, Oda, Katsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067384/
https://www.ncbi.nlm.nih.gov/pubmed/36601953
http://dx.doi.org/10.1111/cas.15717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067384/
https://www.ncbi.nlm.nih.gov/pubmed/36601953
http://dx.doi.org/10.1111/cas.15717

Ejemplares similares